Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUPs B-LONG: Alprolix in Previously Untreated Hemophilia B
NCT02234310Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2014
- Primary completion
- Aug 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 11
01
Overview
A Phase 3 trial of eftrenonacog alfa in hemophilia B (HB), sponsored by Sanofi. Started Nov 2014; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT02234310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234310.